A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin
Authors
Affiliations
Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats. Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans. Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.
Li Y, Lan J, Wong G Biosaf Health. 2025; 5(5):272-279.
PMID: 40078910 PMC: 11895002. DOI: 10.1016/j.bsheal.2023.08.003.
Drupacine as a potent SARS-CoV-2 replication inhibitor .
Yang C, Yu Y, Peng Q, Song J, Sun B, Shi Y Biosaf Health. 2025; 6(5):270-278.
PMID: 40078736 PMC: 11895013. DOI: 10.1016/j.bsheal.2024.09.001.
Ou G, Tang Y, Liu J, Hao Y, Chen Z, Huang T Biosaf Health. 2025; 6(4):225-234.
PMID: 40078666 PMC: 11895047. DOI: 10.1016/j.bsheal.2024.07.002.
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET.
Akil C, Xu J, Shen J, Zhang P bioRxiv. 2025; .
PMID: 40060467 PMC: 11888396. DOI: 10.1101/2025.02.25.640151.
A bivalent spike-targeting nanobody with anti-sarbecovirus activity.
Swart I, Debski-Antoniak O, Zegar A, de Bouter T, Chatziandreou M, van den Berg M J Nanobiotechnology. 2025; 23(1):196.
PMID: 40059135 PMC: 11892322. DOI: 10.1186/s12951-025-03243-y.